Stock comparison
JOHNSON & JOHNSON is 304.8x more valuable than Aurinia Pharmaceuticals Inc. by market capitalization ($618.61 B vs $2.03 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
JNJ is larger
JOHNSON & JOHNSON is 304.8x more valuable than Aurinia Pharmaceuticals Inc. by market capitalization ($618.61 B vs $2.03 B).
Market value leader
JNJ
JOHNSON & JOHNSON is 304.8x more valuable than Aurinia Pharmaceuticals Inc. by market capitalization ($618.61 B vs $2.03 B).
Revenue leader
JNJ
AUPH: $283.06M vs JNJ: $94.19B.
Profit leader
JNJ
AUPH: $287.20M vs JNJ: $26.80B.
Margin leader
AUPH
AUPH: 101.5% vs JNJ: 28.5% net margin.
| Metric | AUPH | JNJ |
|---|---|---|
| Market cap | $2.03 B | $618.61 B |
| US-listed rank | #2119 | #18 |
| Revenue (latest FY) | $283.06M | $94.19B |
| Net income (latest FY) | $287.20M | $26.80B |
| Net margin | 101.5% | 28.5% |
| P/E (trailing FY) | 7.1x | 23.1x |
| SEC filings | 595 | 990 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
JOHNSON & JOHNSON is 304.8x more valuable than Aurinia Pharmaceuticals Inc. by market capitalization ($618.61 B vs $2.03 B).
In their latest fiscal years, Aurinia Pharmaceuticals Inc. reported $283.06M in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: Aurinia Pharmaceuticals Inc. and JOHNSON & JOHNSON, or browse the full rankings.